Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (BCP-ALL) or a B cell lymphoma (BCL) research hub

PREV-CART - A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiotic prophylaxis (AP) in patients treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B cell acute lymphoblastic leukemia or a B cell lymphoma

This study compares two ways to prevent infections in adults with certain blood cancers who are having special cell therapy (CAR T-cells). It looks at whether receiving extra protective antibodies or taking antibiotic medicines works better to keep people healthy after their treatment.